Showing results (81-90 of 369) with videos related to

Sort By:
Pageof 37
Expert Opinion on Pharmacotherapy|June 16, 2023
Pharmacotherapeutic strategies for epithelioid sarcoma: are we any closer to a non-surgical cure?Magdalena Meissner, Andrea Napolitano, Khin Thway, et al.
Current Oncology (Toronto, Ont.)|June 27, 2023
Real-World Outcomes of Stage IV NSCLC with PD-L1 ≥ 50% Treated with First-Line Pembrolizumab: Uptake of Second-Line Systemic TherapyRebekah Rittberg, Bonnie Leung, Aria Shokoohi, et al.
Future Oncology (London, England)|May 12, 2018
Risk-benefit of dexrazoxane for preventing anthracycline-related cardiotoxicity: re-evaluating the European labelingPeter Reichardt, Marie-Dominique Tabone, Jaume Mora, et al.
Marine Drugs|February 17, 2015
Trabectedin in soft tissue sarcomasBradley J Petek, Elizabeth T Loggers, Seth M Pollack, et al.
European Journal of Cancer (Oxford, England : 1990)|September 22, 2009
Pegylated liposomal doxorubicin, an effective, well-tolerated treatment for refractory aggressive fibromatosisAnastasia Constantinidou, Robin L Jones, Michelle Scurr, et al.
European Journal of Cancer (Oxford, England : 1990)|February 8, 2018
Olaratumab in soft tissue sarcoma - Current status and future perspectivesGeorgios Antoniou, Alexander T J Lee, Paul H Huang, et al.
International Journal of Surgical Pathology|July 4, 2020
<i>EWSR1-SMAD3</i>-Positive Fibroblastic TumorOliver Foot, Magnus Hallin, Robin L Jones, et al.
Critical Reviews in Oncology/Hematology|March 9, 2023
The biology and treatment of leiomyosarcomasWilliam G J Kerrison, Khin Thway, Robin L Jones, et al.
Pageof 37